Drug
Sel 068
Sel 068: highest development phase Phase 1, developed by Selecta Biosciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Selecta Biosciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| SEL-068 NCT01478893 | Phase 1 | Smoking Cessation |
Latest
No recent events.
Follow Sel 068 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.